Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation

被引：2
|
作者：
Yanada, Masamitsu [1 ]
Uchida, Naoyuki [2 ]
Ichinohe, Tatsuo [3 ]
Fukuda, Takahiro [4 ]
Kanda, Junya [5 ]
Kanda, Yoshinobu [6 ,7 ]
Atsuta, Yoshiko [8 ,9 ]
Nakasone, Hideki [7 ]
机构：
[1] Aichi Canc Ctr, Nagoya, Aichi, Japan
[2] Toranomon Gen Hosp, Tokyo, Japan
[3] Hiroshima Univ, Res Inst Radiat Biol & Med, Hiroshima, Japan
[4] Natl Canc Ctr, Tokyo, Japan
[5] Kyoto Univ, Grad Sch Med, Kyoto, Japan
[6] Jichi Med Univ, Shimotsuke, Tochigi, Japan
[7] Jichi Med Univ Saitama Med Ctr, Saitama, Japan
[8] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan
[9] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
来源：
BONE MARROW TRANSPLANTATION | 2021年 / 56卷 / 07期
关键词：
RISK-ASSESSMENT;
D O I：
10.1038/s41409-021-01236-7
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1720 / 1722
页数：3
相关论文
共 50 条
  • [21] FASTER LYMPHOCYTE RECOVERY AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) PREDICTS FOR DECREASED NON-RELAPSE MORTALITY (NRM) IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Yuen, C. H.
    Saliba, R. M.
    Andersson, B. S.
    Shpall, E.
    Popat, U. R.
    Qazilbash, M. H.
    Hosing, C.
    de Lima, M. J.
    Giralt, S. A.
    Champlin, R. E.
    Kebriaei, P. M. D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S283 - S283
  • [22] Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia
    Kurosawa, S.
    Yakushijin, K.
    Yamaguchi, T.
    Atsuta, Y.
    Nagamura-Inoue, T.
    Akiyama, H.
    Taniguchi, S.
    Miyamura, K.
    Takahashi, S.
    Eto, T.
    Ogawa, H.
    Kurokawa, M.
    Tanaka, J.
    Kawa, K.
    Kato, K.
    Suzuki, R.
    Morishima, Y.
    Sakamaki, H.
    Fukuda, T.
    BONE MARROW TRANSPLANTATION, 2013, 48 (09) : 1198 - 1204
  • [23] Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia
    S Kurosawa
    K Yakushijin
    T Yamaguchi
    Y Atsuta
    T Nagamura-Inoue
    H Akiyama
    S Taniguchi
    K Miyamura
    S Takahashi
    T Eto
    H Ogawa
    M Kurokawa
    J Tanaka
    K Kawa
    K Kato
    R Suzuki
    Y Morishima
    H Sakamaki
    T Fukuda
    Bone Marrow Transplantation, 2013, 48 : 1198 - 1204
  • [24] Pulmonary Arterial Hypertension (PAH) Is Associated with Increased Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation (allo HCT) for Myelofibrosis
    Gupta, Rohan
    Jamal, Faizi
    Yang, Dongyun
    Ali, Haris
    Aldoss, Ibrahim
    Al Malki, Monzr M.
    Mei, Matthew
    Salhotra, Amandeep
    Dobrin, Surime
    Tran, Michael
    Venkataraman, K.
    Palmer, Joycelynne
    Stein, Anthony S.
    Sandhu, Karamjeet S.
    Khaled, Samer K.
    Aribi, Ahmed
    Marcucci, Guido
    Forman, Stephen J.
    Snyder, David S.
    Nakamura, Ryotaro
    Pullarkat, Vinod
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [25] Failure to Recover Thymopoiesis After Allogeneic Hematopoietic Stem Cell Transplantation Predicts for High Incidence of Opportunistic Infections and Non-Relapse Mortality
    Wils, Evert-Jan
    van der Holt, Bronno
    Broers, Annoek E. C.
    Posthumus-van Sluijs, Sandra J.
    Gratama, Jan W.
    Braakman, Eric
    Cornelissen, Jan J.
    BLOOD, 2010, 116 (21) : 362 - 363
  • [26] Changes In Incidence and Causes of Non-Relapse Mortality (NRM) After Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Are Transplants Improving?
    Kurosawa, Saiko
    Yakushijin, Kimikazu
    Yamaguchi, Takuhiro
    Atsuta, Yoshiko
    Nagamura-Inoue, Tokiko
    Akiyama, Hideki
    Taniguchi, Shuichi
    Miyamura, Koichi
    Takahashi, Satoshi
    Eto, Tetsuya
    Morishima, Yasuo
    Sakamaki, Hisashi
    Fukuda, Takahiro
    BLOOD, 2010, 116 (21) : 397 - 397
  • [27] A PROGNOSTIC MODEL FOR NON-RELAPSE MORTALITY RISK BASED ON MACHINE LEARNING IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION
    Yang, Jingjing
    Zhang, Xiawei
    Dou, Liping
    Liu, Daihong
    BONE MARROW TRANSPLANTATION, 2024, 59 : 310 - 311
  • [28] Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation
    Tanaka, Y.
    Kurosawa, S.
    Tajima, K.
    Tanaka, T.
    Ito, R.
    Inoue, Y.
    Okinaka, K.
    Inamoto, Y.
    Fuji, S.
    Kim, S-W
    Tanosaki, R.
    Yamashita, T.
    Fukuda, T.
    BONE MARROW TRANSPLANTATION, 2016, 51 (04) : 553 - 559
  • [29] Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation
    Y Tanaka
    S Kurosawa
    K Tajima
    T Tanaka
    R Ito
    Y Inoue
    K Okinaka
    Y Inamoto
    S Fuji
    S-W Kim
    R Tanosaki
    T Yamashita
    T Fukuda
    Bone Marrow Transplantation, 2016, 51 : 553 - 559
  • [30] It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)
    Luft, Thomas
    Benner, Axel
    Jodele, Sonata
    Dandoy, Christopher E.
    Storb, Rainer F.
    Gooley, Ted A.
    Sandmaier, Brenda M.
    Radujkovic, Aleksandar
    Ho, Anthony D.
    Dreger, Peter
    Penack, Olaf
    BLOOD, 2016, 128 (22)
12345